. . "H. Lundbeck A/S"@en . . . . . . . . . . . "La Fondation Lundbeck (en danois Lundbeckfonden) est une fondation commerciale danoise. Avec une valeur totale de plus de 65 milliards de couronnes, le fonds figure parmi les plus importants du Danemark. Elle a \u00E9t\u00E9 cr\u00E9\u00E9e en 1954 par Grete Lundbeck, alors la veuve du fondateur de l'entreprise Lundbeck. La fondation soutient la recherche en sciences de la sant\u00E9, avec un accent particulier sur l'\u00E9tude du cerveau, \u00E0 hauteur de 500 millions de couronnes danoises chaque ann\u00E9e. La fondation d\u00E9cerne chaque ann\u00E9e le prix Brain , un prix de recherche dot\u00E9 d'un million euros, attribu\u00E9 \u00E0 un ou plusieurs chercheurs qui ont excell\u00E9 en neurosciences. La fondation d\u00E9tient des actions de contr\u00F4le dans les soci\u00E9t\u00E9s Lundbeck, ALK-Abell\u00F3 et Falck, et investit dans un certain nombre de soci\u00E9t\u00E9s de biotechnologie.."@fr . . . . "H. Lundbeck, conhecida comumente como Lundbeck, \u00E9 uma empresa farmac\u00EAutica global com mais de cem anos de atividade. Especializada em psiquiatria e neurologia. Pesquisa, produz e vende produtos farmac\u00EAuticos para a psiquiatria e neurologia em todo o mundo. Os produtos da empresa s\u00E3o direcionados a \u00E1reas de doen\u00E7as como depress\u00E3o, esquizofrenia, doen\u00E7a de Parkinson e a doen\u00E7a de Alzheimer. Os principais medicamentos da empresa s\u00E3o: Brintellix\u00AE (Vortioxetina), Rexulti (Brexpiprazol), Cipramil\u00AE (Citalopram), Deanxit\u00AE (melitraceno), Clopixol\u00AE (Zuclopentixol), Truxal, Ebix\u2122 (Memantina), Lexapro\u00AE (Escitalopram), Saphris\u00AE (Asenapina) entre outros."@pt . . . "\u9748\u5317\u88FD\u85E5\uFF08\u4E39\u9EA5\u8A9E\uFF1AH. Lundbeck A/S\uFF09\u662F\u4E39\u9EA6\u4E00\u5BB6\u56FD\u9645\u5236\u836F\u516C\u53F8\uFF0C\u5728\u5168\u7403\u9032\u884C\u85E5\u7269\u7814\u767C\u3001\u88FD\u9020\u3001\u884C\u92B7\u3002\u7522\u54C1\u4E3B\u8981\u91DD\u5C0D\u8166\u90E8\u75BE\u75C5\uFF0C\u5305\u62EC\u6182\u9B31\u75C7\u3001\u7CBE\u795E\u5206\u88C2\u75C7\u3001\u963F\u8332\u6D77\u9ED8\u75C7\u3001\u5E15\u91D1\u68EE\u75C5\u548C\u504F\u982D\u75DB\u3002 \u516C\u53F8\u7E3D\u90E8\u4F4D\u65BC\u4E39\u9EA5\u54E5\u672C\u54C8\u6839\uFF0C\u5728 50 \u591A\u500B\u570B\u5BB6\u64C1\u6709 5600 \u540D\u54E1\u5DE5\uFF0C\u5176\u7522\u54C1\u5728 100 \u591A\u500B\u570B\u5BB6\u8A3B\u518A\uFF0C\u4E26\u5728\u4E39\u9EA5\u3001\u6CD5\u570B\u548C\u610F\u5927\u5229\u8A2D\u6709\u751F\u7522\u8A2D\u65BD\uFF0C\u5728\u4E39\u9EA5\u548C\u7F8E\u570B\u6709\u7814\u767C\u4E2D\u5FC3\u3002\u9748\u5317\u5728 2020 \u5E74\u5275\u9020\u4E86 177 \u5104\u4E39\u9EA5\u514B\u6717\u7684\u6536\u5165\u3002 \u7075\u5317\u5728\u54E5\u672C\u54C8\u6839\u8BC1\u5238\u4EA4\u6613\u6240(CSE) \u4E0A\u5E02\uFF0C\u4E5F\u662F\uFF08European Federation of Pharmaceutical Industries and Associations\uFF0CEFPIA\uFF09\u548C\uFF08International Federation of Pharmaceutical Manufacturers & Associations\uFF0CIFPMA\uFF09\u7684\u6210\u5458\u3002"@zh . . "Joerg Hornstein"@en . . . . . . . . . . "\uB8EC\uB4DC\uBCA1(H. Lundbeck A/S, \uBCF4\uD1B5 Lundbeck\uC774\uB77C \uBD88\uB9BC)\uC740 \uB374\uB9C8\uD06C\uC758 \uAD6D\uC81C\uC801\uC778 \uC81C\uC57D\uD68C\uC0AC\uB85C, \uC6B0\uC6B8\uC99D, \uC870\uD604\uBCD1, \uC54C\uCE20\uD558\uC774\uBA38, \uD30C\uD0A8\uC2A8 \uBCD1\uB4F1 \uC911\uCD94\uC2E0\uACBD\uACC4(CNS) \uC57D\uC81C\uB97C \uAC1C\uBC1C\uD558\uACE0 \uD310\uB9E4\uD558\uACE0 \uC788\uB294 \uC81C\uC57D\uD68C\uC0AC\uC774\uB2E4. \uD55C\uAD6D\uC5D4 \uB374\uB9C8\uD06C \uB8EC\uB4DC\uBCA1\uC0AC\uAC00 \uC124\uB9BD\uD55C '\uD55C\uAD6D \uB8EC\uB4DC\uBCA1'\uC774\uB9AC\uB294 \uD55C\uAD6D\uC9C0\uC0AC\uAC00 \uC788\uB2E4."@ko . "Lundbeck"@in . . . . . . . . . . . . . . . . . . . "H. Lundbeck \u2014 \u0434\u0430\u0442\u0441\u043A\u0430\u044F \u0444\u0430\u0440\u043C\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043A\u0430\u044F \u043A\u043E\u043C\u043F\u0430\u043D\u0438\u044F. \u0428\u0442\u0430\u0431-\u043A\u0432\u0430\u0440\u0442\u0438\u0440\u0430 \u0440\u0430\u0441\u043F\u043E\u043B\u043E\u0436\u0435\u043D\u0430 \u0432 \u041A\u043E\u043F\u0435\u043D\u0433\u0430\u0433\u0435\u043D\u0435. \u0421\u043F\u0435\u0446\u0438\u0430\u043B\u0438\u0437\u0438\u0440\u0443\u0435\u0442\u0441\u044F \u043D\u0430 \u043B\u0435\u043A\u0430\u0440\u0441\u0442\u0432\u0430\u0445, \u043F\u0440\u0438\u043C\u0435\u043D\u044F\u0435\u043C\u044B\u0445 \u043F\u0440\u0438 \u043D\u0435\u0440\u0432\u043D\u044B\u0445 \u0440\u0430\u0441\u0441\u0442\u0440\u043E\u0439\u0441\u0442\u0432\u0430\u0445 (\u0430\u043D\u0442\u0438\u0434\u0435\u043F\u0440\u0435\u0441\u0441\u0430\u043D\u0442\u044B, \u0430\u043D\u0442\u0438\u043F\u0441\u0438\u0445\u043E\u0442\u0438\u043A\u0438)."@ru . "H. Lundbeck A/S \u2013 du\u0144ska firma farmaceutyczna za\u0142o\u017Cona w 1915 roku przez , z siedzib\u0105 g\u0142\u00F3wn\u0105 w Kopenhadze. Pocz\u0105tkowo zajmowa\u0142a si\u0119 sprzeda\u017C\u0105 artyku\u0142\u00F3w przemys\u0142owych i spo\u017Cywczych wy\u0142\u0105cznie na rynku du\u0144skim. Z biegiem lat profil firmy ukierunkowywa\u0142 si\u0119 na wytwarzanie i sprzeda\u017C preparat\u00F3w farmaceutycznych i kosmetyk\u00F3w. H. Lundbeck wprowadzi\u0142 do lecznictwa \u015Bwiatowego wiele preparat\u00F3w, mi\u0119dzy innymi antybiotyk neomycyn\u0119, leki przeciwpsychotyczne chloroprotyksen, klopentyksol, zuklopentyksol, sertindol, leki przeciwdepresyjne citalopram, escitalopram. Z pocz\u0105tkiem lat 60. XX wieku rozpocz\u0105\u0142 specjalizacj\u0119 wy\u0142\u0105cznie w kierunku preparat\u00F3w farmaceutycznych wp\u0142ywaj\u0105cych na o\u015Brodkowy uk\u0142ad nerwowy. W 2018 roku firma mia\u0142a oddzia\u0142y w 56 krajach."@pl . "Lundbeck"@ru . . . . . . . . . . . . . . . . . . "H. Lundbeck A/S (bekannt unter Lundbeck) ist ein d\u00E4nisches Pharmazieunternehmen mit Firmensitz in Kopenhagen. Das Unternehmen war zeitweise im Aktienindex OMX Copenhagen 20 gelistet. Lundbeck produziert verschiedene Pharmazieprodukte und verf\u00FCgt in den Indikationen Schizophrenie, Depressionen, Parkinson-Krankheit und Schlafst\u00F6rungen international \u00FCber bedeutende Marktanteile."@de . . . . . . . . . . . "H. Lundbeck A/S (commonly known simply as Lundbeck) is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company\u2019s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Headquartered in Copenhagen, Denmark, Lundbeck has approximately 5,300 employees in more than 50 countries, and their products are registered in more than 100 countries. They have production facilities in Denmark, France and Italy and their research centers are based in Denmark and the US. Lundbeck is listed on the Copenhagen Stock Exchange (CSE). Lundbeck is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)"@en . . . . "H. Lundbeck A/S (umumnya dikenal sebagai Lundbeck saja) adalah perusahaan farmasi internasional Denmark yang bergerak dalam penelitian, pengembangan, manufaktur, pemasaran, dan penjualan obat-obatan di seluruh dunia. Produk-produknya ditujukan untuk penyakit otak, termasuk depresi, skizofrenia, penyakit Alzheimer, penyakit Parkinson, dan migrain. Berkantor pusat di Kopenhagen, Denmark, Lundbeck mempekerjakan 5600 orang di lebih dari 50 negara, dan produk mereka terdaftar di lebih dari 100 negara. Mereka memiliki fasilitas produksi di Denmark, Prancis dan Italia dan pusat penelitian mereka berbasis di Denmark dan Amerika Serikat. Lundbeck menghasilkan pendapatan DKK 17,7 miliar pada tahun 2020. Lundbeck terdaftar di (CSE). Lundbeck adalah anggota penuh dari European Federation of Pharmaceutical Industries and Associations dan International Federation of Pharmaceutical Manufacturers and Associations"@in . "778956"^^ . . "Lundbeck"@en . . . . "15777"^^ . . . . . . . . . . . . "\uB8EC\uB4DC\uBCA1(H. Lundbeck A/S, \uBCF4\uD1B5 Lundbeck\uC774\uB77C \uBD88\uB9BC)\uC740 \uB374\uB9C8\uD06C\uC758 \uAD6D\uC81C\uC801\uC778 \uC81C\uC57D\uD68C\uC0AC\uB85C, \uC6B0\uC6B8\uC99D, \uC870\uD604\uBCD1, \uC54C\uCE20\uD558\uC774\uBA38, \uD30C\uD0A8\uC2A8 \uBCD1\uB4F1 \uC911\uCD94\uC2E0\uACBD\uACC4(CNS) \uC57D\uC81C\uB97C \uAC1C\uBC1C\uD558\uACE0 \uD310\uB9E4\uD558\uACE0 \uC788\uB294 \uC81C\uC57D\uD68C\uC0AC\uC774\uB2E4. \uD55C\uAD6D\uC5D4 \uB374\uB9C8\uD06C \uB8EC\uB4DC\uBCA1\uC0AC\uAC00 \uC124\uB9BD\uD55C '\uD55C\uAD6D \uB8EC\uB4DC\uBCA1'\uC774\uB9AC\uB294 \uD55C\uAD6D\uC9C0\uC0AC\uAC00 \uC788\uB2E4."@ko . . . "H. Lundbeck A/S (commonly known simply as Lundbeck) is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company\u2019s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Lundbeck is listed on the Copenhagen Stock Exchange (CSE)."@en . . . . . . . . "Lundbeck (H. Lundbeck A/S) est une soci\u00E9t\u00E9 pharmaceutique internationale danoise engag\u00E9e dans le d\u00E9veloppement, la production et la commercialisation de m\u00E9dicaments pour le traitement des troubles psychiatriques et neurologiques. Lundbeck est un laboratoire sp\u00E9cialis\u00E9 dans les maladies du Syst\u00E8me Nerveux Central (SNC) : la d\u00E9pendance \u00E0 l'alcool, la d\u00E9pression, la maladie d'Alzheimer, la maladie de Parkinson, la schizophr\u00E9nie, les troubles anxieux et bipolaires."@fr . . . . "\u9748\u5317\u88FD\u85E5"@zh . . . "\u9748\u5317\u88FD\u85E5\uFF08\u4E39\u9EA5\u8A9E\uFF1AH. Lundbeck A/S\uFF09\u662F\u4E39\u9EA6\u4E00\u5BB6\u56FD\u9645\u5236\u836F\u516C\u53F8\uFF0C\u5728\u5168\u7403\u9032\u884C\u85E5\u7269\u7814\u767C\u3001\u88FD\u9020\u3001\u884C\u92B7\u3002\u7522\u54C1\u4E3B\u8981\u91DD\u5C0D\u8166\u90E8\u75BE\u75C5\uFF0C\u5305\u62EC\u6182\u9B31\u75C7\u3001\u7CBE\u795E\u5206\u88C2\u75C7\u3001\u963F\u8332\u6D77\u9ED8\u75C7\u3001\u5E15\u91D1\u68EE\u75C5\u548C\u504F\u982D\u75DB\u3002 \u516C\u53F8\u7E3D\u90E8\u4F4D\u65BC\u4E39\u9EA5\u54E5\u672C\u54C8\u6839\uFF0C\u5728 50 \u591A\u500B\u570B\u5BB6\u64C1\u6709 5600 \u540D\u54E1\u5DE5\uFF0C\u5176\u7522\u54C1\u5728 100 \u591A\u500B\u570B\u5BB6\u8A3B\u518A\uFF0C\u4E26\u5728\u4E39\u9EA5\u3001\u6CD5\u570B\u548C\u610F\u5927\u5229\u8A2D\u6709\u751F\u7522\u8A2D\u65BD\uFF0C\u5728\u4E39\u9EA5\u548C\u7F8E\u570B\u6709\u7814\u767C\u4E2D\u5FC3\u3002\u9748\u5317\u5728 2020 \u5E74\u5275\u9020\u4E86 177 \u5104\u4E39\u9EA5\u514B\u6717\u7684\u6536\u5165\u3002 \u7075\u5317\u5728\u54E5\u672C\u54C8\u6839\u8BC1\u5238\u4EA4\u6613\u6240(CSE) \u4E0A\u5E02\uFF0C\u4E5F\u662F\uFF08European Federation of Pharmaceutical Industries and Associations\uFF0CEFPIA\uFF09\u548C\uFF08International Federation of Pharmaceutical Manufacturers & Associations\uFF0CIFPMA\uFF09\u7684\u6210\u5458\u3002"@zh . "Lundbeck"@pt . "H. Lundbeck A/S \u00E4r ett internationellt danskt l\u00E4kemedelsf\u00F6retag, som har inriktat sig p\u00E5 att ta fram produkter f\u00F6r centrala nervsystemet, bland annat k\u00E4nt f\u00F6r selektiva serotonin\u00E5terupptagsh\u00E4mmare (SSRI) s\u00E5som escitalopram (Cipralex).Lundbeck har cirka 5 000 medarbetare och hade 2005 en oms\u00E4ttning p\u00E5 9,2 miljarder danska kronor. Med b\u00F6rjan vid mitten av 1950-talet tog Lundbeck fram ett antal neuroleptika, d.v.s. antipsykotiska mediciner, av en typ som kallas . Det f\u00F6rsta var Truxal (klorprotixen). Sedan kom Fluanxol (flupentixol), och Sordinol (klopentixol). Det senare har sedan ersatts av Cisordinol (zuklopentizol). P\u00E5 senare \u00E5r har man forskat fram ett nyare neuroleptikum Serdolect (sertindol). Omkring 1960 var Lundbeck ett av de tre l\u00E4kemedelsf\u00F6retag som forskade fram den antidepressiva medicinen amitriptylin, som Lundbeck saluf\u00F6r under varunamnet Saroten. (Medicinen \u00E4r mer k\u00E4nd under MSD:s Tryptizol.) Senare tog man fram den n\u00E4rbesl\u00E4ktade medicinen nortriptylin, som man saluf\u00F6rde under namnet Noritren. I och med uppk\u00F6p av andra l\u00E4kemedelsf\u00F6retag saluf\u00F6r man numera medicinen under namnet Sensaval, som redan tidigare var det mest k\u00E4nda varunamnet. Senare har man forskat fram tv\u00E5 SSRI-preparat - Cipramil (citalopram) och Cipralex (escitalopram)."@sv . . . "Lundbeck"@fr . . . . . . . "H. Lundbeck A/S \u2013 du\u0144ska firma farmaceutyczna za\u0142o\u017Cona w 1915 roku przez , z siedzib\u0105 g\u0142\u00F3wn\u0105 w Kopenhadze. Pocz\u0105tkowo zajmowa\u0142a si\u0119 sprzeda\u017C\u0105 artyku\u0142\u00F3w przemys\u0142owych i spo\u017Cywczych wy\u0142\u0105cznie na rynku du\u0144skim. Z biegiem lat profil firmy ukierunkowywa\u0142 si\u0119 na wytwarzanie i sprzeda\u017C preparat\u00F3w farmaceutycznych i kosmetyk\u00F3w. H. Lundbeck wprowadzi\u0142 do lecznictwa \u015Bwiatowego wiele preparat\u00F3w, mi\u0119dzy innymi antybiotyk neomycyn\u0119, leki przeciwpsychotyczne chloroprotyksen, klopentyksol, zuklopentyksol, sertindol, leki przeciwdepresyjne citalopram, escitalopram. Z pocz\u0105tkiem lat 60. XX wieku rozpocz\u0105\u0142 specjalizacj\u0119 wy\u0142\u0105cznie w kierunku preparat\u00F3w farmaceutycznych wp\u0142ywaj\u0105cych na o\u015Brodkowy uk\u0142ad nerwowy."@pl . . . "\u30EB\u30F3\u30C9\u30D9\u30C3\u30AF\uFF08\u30C7\u30F3\u30DE\u30FC\u30AF\u8A9E: H. Lundbeck A/S\uFF09\u306F\u3001\u3046\u3064\u75C5\u3084\u30A2\u30EB\u30C4\u30CF\u30A4\u30DE\u30FC\u75C5\u306A\u3069\u7CBE\u795E\u795E\u7D4C\u75BE\u60A3\u306B\u95A2\u3059\u308B\u533B\u85AC\u54C1\u306E\u7814\u7A76\u958B\u767A\u30FB\u8CA9\u58F2\u3092\u884C\u3046\u88FD\u85AC\u4F01\u696D\u3002\u30C7\u30F3\u30DE\u30FC\u30AF\u30FB\u30B3\u30DA\u30F3\u30CF\u30FC\u30B2\u30F3\u306B\u672C\u62E0\u3092\u7F6E\u304D\u3001\u4E16\u754C50\u30AB\u56FD\u4EE5\u4E0A\u306B\u62E0\u70B9\u3092\u6301\u3064\u3002\u65E5\u672C\u6CD5\u4EBA\u306F\u30EB\u30F3\u30C9\u30D9\u30C3\u30AF\u30FB\u30B8\u30E3\u30D1\u30F3\u682A\u5F0F\u4F1A\u793E\u3002\u30CA\u30B9\u30C0\u30C3\u30AF\u30FB\u30B3\u30DA\u30F3\u30CF\u30FC\u30B2\u30F3\u4E0A\u5834\u4F01\u696D\uFF08Nasdaq Nordic LUN\uFF09\u3002"@ja . . . "1915"^^ . . . . . . . "Fondation Lundbeck"@fr . . . . . . . . . . . . . . . . . . "H. Lundbeck A/S (umumnya dikenal sebagai Lundbeck saja) adalah perusahaan farmasi internasional Denmark yang bergerak dalam penelitian, pengembangan, manufaktur, pemasaran, dan penjualan obat-obatan di seluruh dunia. Produk-produknya ditujukan untuk penyakit otak, termasuk depresi, skizofrenia, penyakit Alzheimer, penyakit Parkinson, dan migrain. Lundbeck terdaftar di (CSE). Lundbeck adalah anggota penuh dari European Federation of Pharmaceutical Industries and Associations dan International Federation of Pharmaceutical Manufacturers and Associations"@in . . . "Lundbeck (H. Lundbeck A/S) est une soci\u00E9t\u00E9 pharmaceutique internationale danoise engag\u00E9e dans le d\u00E9veloppement, la production et la commercialisation de m\u00E9dicaments pour le traitement des troubles psychiatriques et neurologiques. Lundbeck est un laboratoire sp\u00E9cialis\u00E9 dans les maladies du Syst\u00E8me Nerveux Central (SNC) : la d\u00E9pendance \u00E0 l'alcool, la d\u00E9pression, la maladie d'Alzheimer, la maladie de Parkinson, la schizophr\u00E9nie, les troubles anxieux et bipolaires."@fr . . . . . ""@en . . . . . . . . . . . . . . . . . "H. Lundbeck A/S (bekannt unter Lundbeck) ist ein d\u00E4nisches Pharmazieunternehmen mit Firmensitz in Kopenhagen. Das Unternehmen war zeitweise im Aktienindex OMX Copenhagen 20 gelistet. Lundbeck produziert verschiedene Pharmazieprodukte und verf\u00FCgt in den Indikationen Schizophrenie, Depressionen, Parkinson-Krankheit und Schlafst\u00F6rungen international \u00FCber bedeutende Marktanteile."@de . . . . . . . . . . . "La Fondation Lundbeck (en danois Lundbeckfonden) est une fondation commerciale danoise. Avec une valeur totale de plus de 65 milliards de couronnes, le fonds figure parmi les plus importants du Danemark. Elle a \u00E9t\u00E9 cr\u00E9\u00E9e en 1954 par Grete Lundbeck, alors la veuve du fondateur de l'entreprise Lundbeck. La fondation d\u00E9tient des actions de contr\u00F4le dans les soci\u00E9t\u00E9s Lundbeck, ALK-Abell\u00F3 et Falck, et investit dans un certain nombre de soci\u00E9t\u00E9s de biotechnologie.."@fr . . . . . . . . "Lundbeck"@de . . . "Lundbeck"@sv . . . "Deborah Dunsire"@en . "1112448595"^^ . . . . . "H. Lundbeck"@pl . . . . "\u30EB\u30F3\u30C9\u30D9\u30C3\u30AF"@ja . . . . . "H. Lundbeck, conhecida comumente como Lundbeck, \u00E9 uma empresa farmac\u00EAutica global com mais de cem anos de atividade. Especializada em psiquiatria e neurologia. Pesquisa, produz e vende produtos farmac\u00EAuticos para a psiquiatria e neurologia em todo o mundo. Os produtos da empresa s\u00E3o direcionados a \u00E1reas de doen\u00E7as como depress\u00E3o, esquizofrenia, doen\u00E7a de Parkinson e a doen\u00E7a de Alzheimer."@pt . "\uB8EC\uB4DC\uBCA1"@ko . "Lundbeck.svg"@en . . . "H. Lundbeck A/S"@en . "Hans Lundbeck"@en . . . . . . . . . "H. Lundbeck A/S \u00E4r ett internationellt danskt l\u00E4kemedelsf\u00F6retag, som har inriktat sig p\u00E5 att ta fram produkter f\u00F6r centrala nervsystemet, bland annat k\u00E4nt f\u00F6r selektiva serotonin\u00E5terupptagsh\u00E4mmare (SSRI) s\u00E5som escitalopram (Cipralex).Lundbeck har cirka 5 000 medarbetare och hade 2005 en oms\u00E4ttning p\u00E5 9,2 miljarder danska kronor."@sv . . . "\u30EB\u30F3\u30C9\u30D9\u30C3\u30AF\uFF08\u30C7\u30F3\u30DE\u30FC\u30AF\u8A9E: H. Lundbeck A/S\uFF09\u306F\u3001\u3046\u3064\u75C5\u3084\u30A2\u30EB\u30C4\u30CF\u30A4\u30DE\u30FC\u75C5\u306A\u3069\u7CBE\u795E\u795E\u7D4C\u75BE\u60A3\u306B\u95A2\u3059\u308B\u533B\u85AC\u54C1\u306E\u7814\u7A76\u958B\u767A\u30FB\u8CA9\u58F2\u3092\u884C\u3046\u88FD\u85AC\u4F01\u696D\u3002\u30C7\u30F3\u30DE\u30FC\u30AF\u30FB\u30B3\u30DA\u30F3\u30CF\u30FC\u30B2\u30F3\u306B\u672C\u62E0\u3092\u7F6E\u304D\u3001\u4E16\u754C50\u30AB\u56FD\u4EE5\u4E0A\u306B\u62E0\u70B9\u3092\u6301\u3064\u3002\u65E5\u672C\u6CD5\u4EBA\u306F\u30EB\u30F3\u30C9\u30D9\u30C3\u30AF\u30FB\u30B8\u30E3\u30D1\u30F3\u682A\u5F0F\u4F1A\u793E\u3002\u30CA\u30B9\u30C0\u30C3\u30AF\u30FB\u30B3\u30DA\u30F3\u30CF\u30FC\u30B2\u30F3\u4E0A\u5834\u4F01\u696D\uFF08Nasdaq Nordic LUN\uFF09\u3002"@ja . "225"^^ . . . . . . . . . . . . . . "H. Lundbeck \u2014 \u0434\u0430\u0442\u0441\u043A\u0430\u044F \u0444\u0430\u0440\u043C\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043A\u0430\u044F \u043A\u043E\u043C\u043F\u0430\u043D\u0438\u044F. \u0428\u0442\u0430\u0431-\u043A\u0432\u0430\u0440\u0442\u0438\u0440\u0430 \u0440\u0430\u0441\u043F\u043E\u043B\u043E\u0436\u0435\u043D\u0430 \u0432 \u041A\u043E\u043F\u0435\u043D\u0433\u0430\u0433\u0435\u043D\u0435. \u0421\u043F\u0435\u0446\u0438\u0430\u043B\u0438\u0437\u0438\u0440\u0443\u0435\u0442\u0441\u044F \u043D\u0430 \u043B\u0435\u043A\u0430\u0440\u0441\u0442\u0432\u0430\u0445, \u043F\u0440\u0438\u043C\u0435\u043D\u044F\u0435\u043C\u044B\u0445 \u043F\u0440\u0438 \u043D\u0435\u0440\u0432\u043D\u044B\u0445 \u0440\u0430\u0441\u0441\u0442\u0440\u043E\u0439\u0441\u0442\u0432\u0430\u0445 (\u0430\u043D\u0442\u0438\u0434\u0435\u043F\u0440\u0435\u0441\u0441\u0430\u043D\u0442\u044B, \u0430\u043D\u0442\u0438\u043F\u0441\u0438\u0445\u043E\u0442\u0438\u043A\u0438)."@ru . . . . . . . . .